Clinical Trials Managers
Overall Exposure
2025 vs 2023
Theoretical Exposure
73What AI could do
Observed Exposure
35What AI actually does
Automation Risk Score
36Displacement risk
3-Year Outlook (2025 โ 2028)
Projected changes in AI automation metrics over the next 3 years based on estimated data.
Overall Exposure
2025 โ 2028 (estimated)
Theoretical Exposure
2025 โ 2028 (estimated)
Observed Exposure
2025 โ 2028 (estimated)
Automation Risk
2025 โ 2028 (estimated)
Exposure Metrics (2023 - 2028)
Detailed Metrics Table
| Year | Overall | Theoretical | Observed | Risk | Data Type |
|---|---|---|---|---|---|
| 2024 | 48 | 68 | 28 | 30 | actual |
| 2025 | 54 | 73 | 35 | 36 | estimated |
| 2026 | 59 | 77 | 41 | 41 | estimated |
| 2027 | 64 | 81 | 47 | 46 | estimated |
| 2028 | 68 | 84 | 52 | 50 | estimated |
Task Breakdown
About This Occupation
If you work as a Clinical Trials Manager, AI is augmenting your data monitoring and documentation tasks. With an automation risk of 36/100 and overall exposure at 54%, this role faces high transformation. Trial data monitoring sees the highest automation at 65%. BLS projects +10% growth through 2034.
Frequently Asked Questions
With an automation risk score of 36%, Clinical Trials Managers faces a moderate level of AI-driven change. Some tasks can be automated, but many require human judgment, creativity, or interpersonal skills that AI cannot yet replicate. The role is more likely to evolve alongside AI than be replaced.
The AI automation risk score for Clinical Trials Managers is 36% (2025 data). Overall AI exposure is 54%, with 73% theoretical exposure and 35% observed exposure. The risk trend from 2023 to 2025 is 0 points.
The tasks with the highest automation potential for Clinical Trials Managers are: Monitor trial data for compliance and safety signals (65%), Prepare regulatory submission documents (55%), Manage clinical site relationships and staff (20%). These rates reflect how much of each task current AI systems can handle, based on research data from Anthropic and academic sources.
The BLS projects +10% employment change for Clinical Trials Managers from 2024 to 2034. Combined with an overall AI exposure of 54%, this occupation is experiencing both traditional labor market shifts and AI-driven transformation. Workers should monitor both employment trends and AI capability growth.
Since AI primarily augments capabilities in this role, professionals in Clinical Trials Managers should embrace AI as a productivity multiplier. Focus on learning to use AI tools effectively, developing higher-order analytical and creative skills, and positioning yourself as someone who can leverage AI to deliver greater value.